King’s International Consortium is established

Five of the most innovative and internationally recognised healthcare providers from the UK’s National Health Service join together to establish King’s International Consortium.

King’s International Consortium, the UK’s first with the support of the NHS Export Collaborative, has been established. The consortium launched at an event in London on 24 January 2023 and was presided over by Lord Prior, former Chair of the NHS.

The five consortium members are King’s College Hospital NHS Foundation Trust, Guy’s and St Thomas’ NHS Foundation Trust, Cambridge University Hospitals NHS Foundation Trust, The Christie NHS Foundation Trust, and Moorfields Eye Hospital NHS Foundation Trust. It has the support of the NHS Export Collaborative, Healthcare UK, NHS England and the Department of Health and Social Care.

The establishment of the NHS Export Collaborative and consortia is part of the 2019 NHS long-term plan, and aims to generate additional income and investment for the benefit of NHS patients.

The King’s International Consortium members have over 1,000 years of combined experience in delivering excellent and high-quality care to patients, both across the UK and internationally, and have a proven record of accomplishment in delivering international projects and offering expertise across all clinical specialities.

Charles Alexander, Joint Chair for Guy’s and St Thomas’ and King’s, Dr Mike More, Chair for Cambridge University Hospitals, Christine Outram MBE, Chair for The Christie, and Ros Given-Wilson, Interim Chair for Moorfields, released a joint statement of support.

“We are delighted to have established King’s International Consortium, which brings together five of the most innovative and internationally recognised healthcare providers from the UK’s National Health Service (NHS).

“The aim of King’s International Consortium is to export British healthcare collaboratively, by working in partnership with external investors to deliver large-scale international healthcare projects, to market our world-class capabilities and to bring in additional income and investment for the benefit of NHS patients.

This innovation, the first of its kind in the UK, will strengthen our position as being leaders in the field of exporting NHS standards of care and quality.

We are grateful to the NHS Export Collaborative and Healthcare UK, as well as NHS England and The Department of Health and Social Care.

We are committed to ensuring the King’s International Consortium is a success for its partners and the NHS.”

At the launch event, Lord Prior, former Chair of the NHS said:

“This is a great achievement and I wanted to congratulate those who put this strong consortium of NHS member Trusts together. I am excited and encouraged for the future of King’s International Consortium and for the opportunities the members will have by working together.”

Dr Aphrodite Spanou, Director for Science and Technology (S&T) Directorate – Department for International Trade said:

“King’s International Consortium is a vanguard model of collaborative working. Healthcare UK has eagerly followed and supported its establishment as they create a combined global healthcare presence. I am pleased to be invited to this launch event and congratulate its members on the innovations they deliver that make a difference to patients at home and abroad.”

All services delivered by the King’s International Consortium will be managed via King’s Commercial Services.

For more information, please use the contact details below:

Nigel Brinklow | Head of International PlatformsKch-tr.EnquiriesKingscommercial@nhs.net
Emails: Add “Consortium” to the subject field
+44 (0)20 3299 7560

King’s College Hospital NHS Foundation Trust
Established in 1840, King’s has been at the forefront of medical innovation for more than 180 years. The Trust is recognised internationally for its work in liver disease and transplantation, neurosciences, cardiac, haemato-oncology, stroke and major trauma. The Trust’s hospitals include King’s College Hospital (Denmark Hill), the Princess Royal University Hospital (PRUH), and Orpington Hospital – it also provide some services at Beckenham Beacon and Queen Mary’s Hospital, Sidcup.

Guy’s and St Thomas’ Hospital NHS Foundation Trust
Guy’s and St Thomas’ NHS Foundation Trust has a proud history stretching back over 900 years, and is now one of the largest hospital Trusts in the United Kingdom; world famous for medical breakthroughs and innovation, staff continue to live up to these pioneering traditions through their commitment to clinical excellence and high levels of patient satisfaction. The Trust is proud of its long tradition of undertaking ground-breaking research, educating the future workforce and engaging with partners in order to drive forward innovations that benefit patients.

Cambridge University Hospitals NHS Foundation Trust
Cambridge University Hospitals (CUH) is a family of hospitals comprising Addenbrooke’s and The Rosie. It is a regional centre of excellence for specialist services such as organ transplantation, neurosciences, paediatrics and genetics and is a leading national centre for specialist treatment for rare or complex conditions. A beacon of clinical, academic and research excellence CUH is uniquely situated in the centre of the 157 acre Cambridge Biomedical Campus, which also includes the University of Cambridge, Papworth, AstraZeneca’s global HQ and research centres, GSK, the Wellcome Trust, Cancer Research UK and MRC Laboratory of Molecular Biology.

The Christie NHS Foundation Trust
The Christie is Europe’s largest single site cancer centre and one of only two centres in the world to offer both MR-linac and high-energy proton beam therapy. It was one of the first UK hospitals to be accredited as a comprehensive cancer centre and has a proven track record of clinical excellence, building on more than 100 years of innovation in cancer care, research and education. The Christie has extensive experience of advising on large-scale international projects including The Fujian Lin Wenjing Memorial Hospital, China, and the Glandore Centre, Cork University Hospital, Ireland. Additionally, The Christie is also working in partnership with King’s to support the African Medical Centre of Excellence in Nigeria.

Moorfields Eye Hospital NHS Foundation Trust
Moorfields Eye Hospital the leading provider of eye health services in the UK and a world-class centre of excellence for ophthalmic research and education. It has a reputation, developed over two centuries, for providing the highest quality of ophthalmic care. Moorfields Eye Hospital international experience includes the operation of an Eye Hospital in Dubai and a JV in Abu Dhabi, UAE.

King’s Commercial
KCH Management Ltd (King’s Commercial) is a wholly owned subsidiary of King’s College Hospital NHS Foundation Trust and was established in 2007. We develop commercial opportunities with local and international clients on behalf of King’s. All income that we generate is reinvested in the Trust’s NHS activity. King’s Commercial has built up significant experience of international partnerships with partner facilities open, or under construction, in the United Arab Emirates, Kingdom of Saudi Arabia and Nigeria with others in the pipeline.

NHS Export Collaborative
The NHS Export Collaborative was established to make it easier for NHS organisations to collaborate in exporting UK healthcare expertise overseas, and by doing so contribute to global health outcomes. The NHS Export Collaborative is a partnership initiative between NHS England (NHSE), Healthcare UK (HCUK) and Department of Health and Social Care (DHSC) and is hosted in the Department for International Trade.

Healthcare UK
Healthcare UK supports UK organisations to do more business overseas, by promoting the UK healthcare sector to overseas markets and supporting healthcare partnerships between the UK and overseas healthcare providers. This includes partnering with a wide range of UK private and public sector organisations.